Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First Line Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14903
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Editorial: Paradoxical Skin Lesions During Anti-TNF Treatment-An Additional Argument to Consider New Biologics as First-Line Therapy in Inflammatory Bowel Disease. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Editorial: An Argument for Low-Dose Thiopurine Allopurinol Combination Use as First-Line Therapy in Inflammatory Bowel Disease-Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Letter: Paradoxical Skin Eruptions During Anti-TNF-Α Treatment of Crohn's Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

P095 Inflammatory Bowel Disease, During Anti IL 17 Treatment

2019English

Complications and Optimalisation of Mesalazine and Anti-TNF-Alpha Therapy in Inflammatory Bowel Disease

English

Implementable Strategies and Exploratory Considerations to Reduce Costs Associated With Anti-TNF Therapy in Inflammatory Bowel Disease

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2014English

The Effect of Anti-TNF Therapy on Thyroid Function in Patients With Inflammatory Bowel Disease

Endocrine Journal
EndocrinologyMetabolismDiabetes
2018English

Review Article: Managing the Adverse Events Caused by Anti-TNF Therapy in Inflammatory Bowel Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy